A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

Clinical trial NCT00454896 · COMPLETED

Trial details

NCT number: NCT00454896
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2004-05-01
Primary completion: 2005-09-01
Enrollment: 739

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.